A prospective, registry based, observational study to asses maternal, fetal and infant outcomes following exposure to lasmiditan (H8H-MC-B001)

05/01/2022
16/10/2025
EU PAS number:
EUPAS44973
Study
Ongoing

ENCePP Code of conduct

No
Data sources

Data sources (types)

Other

Data sources (types), other

Prospective patient-based data collection
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No